Her email is Janet underscore yellen at FRB fot gov.
I have been investing in the biotech sector for 24+ years. With all due respect, I don’t appreciate your public comments stating the small biotech stocks are overvalued. A person in your position should be very cautious about singling out a sector and calling it “overvalued”. Have you tracked the industry in detail? Are you a biotech valuation analyst/expert? I suggest you retract these ill-advised statements and refrain from such comments in the future.
I can see the market is very excited about his hiring, down almost 4%. I guess they figure no ST buyout now.
I am doing everything possible as a shareholder (without a controlling interest) to make something happen. This price/valuation is just unacceptable.
For 21 days the headline story for IMGN has been the negative MS report and low price target. For how long will it last? Does IMGN have new options being priced? Come one man, let's get something positive on top!!! Is there nothing good happening at IMGN? Lots of hiring to add to their cost/losses, or maybe these are replacements?
Not impressed, I would have preferred they hired someone from Trius, or someone with an MBA. This guy looks like an accountant and lawyer, not a business professional. Maybe he can play a dual role in accounting and legal and save them some cash, that's the only plus I see.
Most small companies outsource manufacturing to firms that specialize in it, although ARNA set up their own facility to manufacture a similar drug. Maybe ACAD should talk to ARNA about Mfg? It's not a big deal and should not be expensive relative to their high levels of cash. Pima is a small molecule (relatively simple to mfg), not a biologic (complex to mfg).
DSCO was one of the best sales/exits of my life and has always been a POS because Cooper the CEO is a dope. Unless something has changes, beware.
Thanks very interesting and encouraging regarding future TDM1 revs/royalty payments and of course positive for patients. They mentioned a 2016 date for first line, but I thought we had a read out coming in 2H 2014. Maybe 2014 is PFS and 2016 is OS?
Great to see the positive news. If your execs had not borrowed from Deerfield, the stock would be much higher, they are a cancer on any stock they own and I do mean own. The sooner your people can buy them off, the better. There must be a joke about the difference between a Deerfield financier and a mob boss, or someone should make one up. GL, no positions.
Posting FUD and impersonating furiously. Poster needs to get a real job. We will pray for your soul, that you don't burn in hell for eternity.
agreed, I get annoyed that every time I click on the Yahoo MB the headline is the negative MS report. IR needs to get something positive out!
the earliest the product could launch is probably mid 2015, they have plenty of time and would be wise to not hire too many people prior to approval. Or, a sale would be fine with me.
I prefer they spend time getting their application filing correct, that's the only key job they need to focus on other than lining up potential partners and lining up new employees to hire for the launch, which should be very slow and careful to keep the burn/risk down in case of an unexpected delay.
Never buy ARNA calls except for long tern, in the money as a stock replacement strategy when the premium is low. All of the other calls expire worthless. Selling the LT $5 puts is a better strategy IMO, but that requires capital, which most people who speculate on calls do not have.
Nice work IMGN execs! Please do let us know if anything positive ever happens there, it's been about 2 years since shareholders had any good news. "Exciting times" more low-priced, free options for the execs!